Congressional pressure on pharmacy benefit managers continued to mount Wednesday as the Senate Finance Committee approved another bipartisan measure to curb the industry’s business practices. The panel voted 26 to 0 to refer the Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023 to the full Senate, with Sen. Ron Johnson (R-Wis.) declining to cast a vote. In addition to a slew of Medicare and Medicaid payment policies, the bill seeks to reduce prescription drug costs by imposing new rules on PBMs and health insurance companies.
Read the full article: PBMs Face More Restrictions under New Senate Bill //
Source: https://www.modernhealthcare.com/politics-policy/pharmacy-benefit-manager-pbm-pharmacies-senate-finance-bill